Low frequency missense variants in the ANGPTL4 (E40K) gene protect against the risk of CAD [13] and ANGPTL3 loss-of-function mutations reduce the risk of CAD in humans [5]. The gene discussed is ANGPTL4; the disease is coronary artery disorder.